Venus Concept Inc
VERO2.480USD
-0.040-1.59%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
1.76MCap. mercado
PérdidaP/E TTM
Más Datos de Venus Concept Inc Compañía
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and 10 direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Información de la empresa
Símbolo de cotizaciónVERO
Nombre de la empresaVenus Concept Inc
Fecha de salida a bolsaOct 12, 2017
Director ejecutivoMr. Rajiv De Silva
Número de empleados292
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 12
Dirección235 Yorkland Blvd Suite 900
CiudadTORONTO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísCanada
Código postalM2J 4Y8
Teléfono18778488430
Sitio Webhttps://www.venusconcept.com/en-uk/
Símbolo de cotizaciónVERO
Fecha de salida a bolsaOct 12, 2017
Director ejecutivoMr. Rajiv De Silva
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Kirk Gunhus
Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
--
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+0.13%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+0.64%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
Ms. Melissa Kang, CPA
Ms. Melissa Kang, CPA
Chief Product Officer
Chief Product Officer
--
--
Ms. Louise M. Lacchin
Ms. Louise M. Lacchin
Independent Director
Independent Director
--
--
Mr. Scott Barry
Mr. Scott Barry
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Domenic Della Penna, CPA
Mr. Domenic Della Penna, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Kirk Gunhus
Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
--
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+0.13%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+0.64%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Products—Systems
7.90M
57.93%
Subscription—Systems
2.65M
19.42%
Products—Other
2.42M
17.74%
Services
671.00K
4.92%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
8.41M
61.62%
International
5.24M
38.38%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Products—Systems
7.90M
57.93%
Subscription—Systems
2.65M
19.42%
Products—Other
2.42M
17.74%
Services
671.00K
4.92%
Estadísticas de accionistas
Actualizado: mar., 15 de jul
Actualizado: mar., 15 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
Madryn Asset Management, LP
0.55%
UBS Financial Services, Inc.
0.49%
Other
85.94%
Accionistas
Accionistas
Proporción
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
Madryn Asset Management, LP
0.55%
UBS Financial Services, Inc.
0.49%
Other
85.94%
Tipos de accionistas
Accionistas
Proporción
Venture Capital
7.54%
Investment Advisor
5.97%
Individual Investor
0.82%
Private Equity
0.55%
Hedge Fund
0.10%
Other
85.03%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
48
303.41K
16.32%
+73.80K
2025Q1
57
222.57K
25.52%
+13.74K
2024Q4
59
229.67K
34.82%
+28.01K
2024Q3
64
3.05M
44.61%
-537.66K
2024Q2
70
3.54M
52.45%
+304.55K
2024Q1
74
3.18M
52.95%
-445.34K
2023Q4
77
2.92M
53.20%
-420.44K
2023Q3
87
3.15M
119.91%
-295.52K
2023Q2
98
3.14M
119.96%
-1.42M
2023Q1
124
4.18M
259.89%
-397.96K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Orca Capital GmbH
101.75K
5.47%
+101.75K
--
Jun 06, 2025
EW Healthcare Partners
99.02K
5.33%
+3.00
+0.00%
Jun 09, 2025
HealthQuest Capital Management, L.P
41.19K
2.22%
--
--
Dec 31, 2024
Madryn Asset Management, LP
10.19K
0.55%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
9.19K
0.49%
+4.02K
+77.78%
Mar 31, 2025
De Silva (Rajiv)
7.58K
0.41%
--
--
Apr 28, 2025
Tower Research Capital LLC
1.78K
0.1%
+1.14K
+176.28%
Mar 31, 2025
Hollmig (Stanley Tyler)
1.76K
0.09%
--
--
Apr 28, 2025
Gunhus (Kirk)
1.64K
0.09%
+1.64K
--
Apr 28, 2025
Varghese (Hemanth Jacob)
1.52K
0.08%
+1.00
+0.07%
Apr 28, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
Fecha
Tipo
Relación
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
